Selective Translation of Maternal mRNA by eIF4E1B Controls Oocyte to Embryo Transition
Advanced Science · 2023
DOI: 10.1002/advs.202205500 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2023. Verfasst von Jing Guo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Center for Reproduction and Genetics in Hunan Province, Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha, 410078, P. R.…. Hauptthemen laut MEDLINE: Eukaryotic Initiation Factor-4E, Oocytes, RNA, Messenger, Stored. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province, Scientific Research Foundation of Reproductive and Genetic Hospital of CITIC-Xiangya.
Abstract (Originalsprache)
Maternal messenger ribonucleic acids (mRNAs) are driven by a highly orchestrated scheme of recruitment to polysomes and translational activation. However, selecting and regulating individual mRNAs for the translation from a competitive pool of mRNAs are little‐known processes. This research shows that the maternal eukaryotic translation initiation factor 4e1b ( Eif4e1b ) expresses during the oocyte‐to‐embryo transition (OET), and maternal deletion of Eif4e1b leads to multiple defects concerning oogenesis and embryonic developmental competence during OET. The linear amplification of complementary deoxyribonucleic acid (cDNA) ends, and sequencing (LACE‐seq) is used to identify the distinct subset of mRNA and its CG‐rich binding sites within the 5′ untranslated region (UTR) targeted by eIF4E1B. The proteomics analyses indicate that eIF4E1B‐specific bound genes show stronger downregulation at the protein level, which further verify a group of proteins that plays a crucial role in oocyte maturation and embryonic developmental competence is insufficiently synthesized in Eif4e1b ‐cKO oocytes during OET. Moreover, the biochemical results in vitro are combined to further confirm the maternal‐specific translation activation model assembled by eIF4E1B and 3′UTR‐associated mRNA binding proteins. The findings demonstrate the indispensability of eIF4E1B for selective translation activation in mammalian oocytes and provide a potential network regulated by eIF4E1B in OET.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Research Center for Reproduction and Genetics in Hunan Province, Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha, 410078, P. R. China.
- Key Laboratory of RNA Biology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, P. R. China.
- University of Chinese Academy of Sciences, Beijing, 100049, P. R. China.
- Laboratory of Reproductive and Stem Cell Engineering, NHC Key Laboratory of Human Stem Cell and Reproductive Engineering, Central South University, Changsha, 410078, P. R. China.
ORCID-Profile: Jing Guo
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
- Scientific Research Foundation of Reproductive and Genetic Hospital of CITIC-Xiangya
Zitieren
APA
Guo, J., Zhao, H., Zhang, J., Lv, X., Zhang, S., Su, R., Zheng, W., Dai, J., Meng, F., Gong, F., Lu, G., Xue, Y., & Lin, G. (2023). Selective Translation of Maternal mRNA by eIF4E1B Controls Oocyte to Embryo Transition. Advanced Science. https://doi.org/10.1002/advs.202205500
Vancouver
Guo J, Zhao H, Zhang J, Lv X, Zhang S, Su R, et al. Selective Translation of Maternal mRNA by eIF4E1B Controls Oocyte to Embryo Transition. Advanced Science. 2023. doi:10.1002/advs.202205500
BibTeX
@article{Guo2023,
author = {Guo, Jing and Zhao, Hailian and Zhang, Jue and Lv, Xiangjiang and Zhang, Shen and Su, Ruibao and Zheng, Wei and Dai, Jing and Meng, Fei and Gong, Fei and Lu, Guangxiu and Xue, Yuanchao and Lin, Ge},
title = {Selective Translation of Maternal mRNA by eIF4E1B Controls Oocyte to Embryo Transition},
journal = {Advanced Science},
year = {2023},
doi = {10.1002/advs.202205500}
}
EUVIMED